|
Efficacy of Chlorhexidine-Containing Cutaneous Antiseptics in
Prevention of (Vascular) Catheter Related Infection.
Andrew Longmate
on behalf of the SICS EBM group
Intensive
Care Unit, Stirling Royal Infirmary, Livilands, Stirling FK8 2AU
Correspondence: Andrew.Longmate@fvah.scot.nhs.uk
Citation:
EBM Reviews. Scottish Intensive Care Society EBM Group.
Andrew Longmate. Efficacy of
Chlorhexidine-Containing Cutaneous Antiseptics in Prevention of (Vascular)
Catheter Related Infection. 2005
Background:
(Vascular) Catheter related
bloodstream infection is associated with an increased morbidity, mortality,
length of hospitalization and medical costs.
The pathophysiology of catheter related
infection remains uncertain but three main possibilities have been identified.
These include skin colonisation and invasion of the transcutaneous insertion
tract by micro-organisms of the patient ‘s own flora, hub colonisation with
contiguous intraluminal spread or infusate contamination.
Heavy cutaneous colonisation is a
risk factor for CVC related BSI and chlorhexidine is a potent germicide that has
been used for many years for skin disinfection.
Multimodal strategies are important in the prevention of intensive care
associated infections including catheter related blood stream infections.
However Chlorhexidine containing cutaneous antiseptics have been widely
recommended for use prior to catheter insertion to prevent CrBSI.
Objectives:
The objectives of this search was
to assess published RCTs and meta-analyses that have attempted to address
whether the use of chlorhexidine skin preparation may be beneficial in
preventing catheter related bloodstream infection.
Search strategy:
Medline(1) catheterisation (explode)
(2) catheterisation/ or catheterization, Swan-Ganz/ or Heart Catheterization/ or
ctaheterisation.mp or Catheterization, Central venous (3) 1 and 2 (4)infection
or infection m.p. (5) 3 and 4 (6) limit 5 to English language and "all adult(19
plus years)" and meta analysis. (7) limit 5 to "all adult(19 plus years)" and
randomised controlled trial (8) 6 or 7. This resulted in 21 publications.
Additional hand searches of reference lists from these publications and review
articles.
Selection criteria:
RCTs or meta-analysis published in peer
reviewed journals comparing rates of catheter colonization or infection between
different antiseptic skin regimes prior to insertion of vascular catheter
(arterial or central venous catheter).
Excluded tunnelled catheters, antimicrobial impregnated catheters, non adult
patients and non ITU patients, insertion site infections and articles not
published in English language. Studies presented at meetings or in abstract form
were also excluded.
Definitions:
Definitions used vary between different
studies which can make comparisons confusing. For the purposes of this review
the results have been limited to 2 main groups: catheter colonization and
bacteraemic catheter related blood stream infection.
-
Colonisation:
is clearly a surrogate marker which
fits with one potential mechanism of infection which assumes that catheter
colonisation is a key step to catheter related blood stream infection. It may
not have direct clinical implications. The 3 main ways to define colonisation
include
•
Qualitative: isolation of
organism from catheter tip.
•
Semiquantative: Greater or equal
to 15 colony forming units (by roll plate technique)
•
Quantitative estimation: greater
than 10 3 bacteria
-
Bacteraemic Catheter Related
Blood Stream Infection:
can be defined as bacteraemia (or fungaemia) in a patient with an
intravascular catheter with at least one positive blood culture obtained from
a peripheral vein , clinical manifestations of infection (ie fever, chills
and/or hypotension) and no apparent source of BSI except the catheter. One of
the following should be present: a positive semiquantitative (>15cfu/catheter
segment) or quantitative (>103 cfu/catheter segment cartheter)
culture whereby the same organism (species and antibiogram) is isolated from
the catheter segment and the peripheral blood. (from CDC definition)
Search results:
Produce 5 papers – Four RCTs1-4,
one meta-analysis5.
Analysis of the Evidence:
-
Colonisation
(Data was analysed by CATmakerTM software)
- 2 Trials showed a significant reduction in
colonisation using chlorhexidine compared to povidone iodine(1,2).
- 2 Trials showed no significant difference
(3,4). One study was not adequately powered to detect a difference(3) and the
other (4) showed a trend towards reduction.
- 1 Trial Showed that combination
iodine/chlorhexidine better than either alone for prevention of colonisation
(4).
Central Venous
Catheters
|
|
First Author of Trial (refernce): |
Maki (1) |
Mimoz (2) |
Humar (3) |
Langgartner (4) |
|
Colonisation definition |
>
15cfus |
>/=103 cfus/ml |
>
15cfus |
>
15cfus |
|
Control
Group
|
Control Agent(s) |
10%
povidone iodine or 70% alcohol |
10%
povidone iodine |
10%
povidone iodine |
10% povidone iodine |
|
%
incidence |
18.3% |
|
27% |
30.8% |
|
(numbers) |
20/109 |
|
24/88 |
16/52 |
|
per
1000 pat days |
|
31 |
46 |
21 |
|
Chlorhexidine |
Formulation |
2%
aqueous |
0.25%
4%
alcohol |
0.5% tincture |
0.5%
70%
alcohol |
|
%
incidence |
5.9% |
|
34% |
24.4% |
|
(numbers) |
4/67 |
|
31/92 |
11/45 |
|
per
1000 pat days |
|
8 |
34 |
18.8 |
|
Sequential |
%
incidence |
|
|
|
4.7% |
|
|
(numbers) |
|
|
|
2/43 |
|
|
per
1000 pat days |
not
tested |
not
tested |
not
tested |
3.5 |
|
Chlorhex. v. Iodine |
RR(95% CI)
Relative Risk |
0.33
(0.26-0.39)
reduction |
|
1.24
(1.16-1.31)
N/S
|
0.79 (0.71-0.87)
*
|
*
Apparently shows significant reduction. Not verified by authors.
|
Central Venous
Catheters
and Arterial Catheters |
|
First Author of Trial: |
Maki |
Mimoz |
Humar |
Langgartner |
|
Colonisation definitions |
>
15cfus |
>/=103 cfus per ml |
|
|
|
Control
Group
|
Control Agent(s) |
10%
povidone iodine or 70% alcohol |
10%
povidone iodine |
|
|
|
%
incidence |
7% |
17% |
|
|
|
(numbers) |
32/454 |
24/145 |
|
|
|
per
1000 pat days |
not
given |
31 |
|
|
|
Chlor hex. |
Formulation |
2%
aqueous |
0.25%
4%
alcohol |
|
|
|
%
incidence |
2.3% |
7.1% |
|
|
|
(numbers) |
5/214 |
12/170 |
|
|
|
per
1000 pat days |
not
given |
12 |
|
|
|
Sequential |
%
incidence |
|
|
|
|
|
|
(numbers) |
|
|
|
|
|
|
per
1000 pat days |
not
tested |
not
tested |
|
|
|
Chlor hex. v. Iodine |
RR(95% CI)
Relative Risk |
0.33
(0.3-0.37)
reduction |
0.43 check
(0.37-0.48)
reduction |
|
|
-
Catheter Related Bacteraemic Blood
Stream Infection (BSI)
|
CVCs and a lines |
|
First Author of Trial: |
Maki |
Mimoz |
Humar |
|
Catheter Realated Bacteraemia |
|
|
|
|
Control
Group
|
Control Agent(s) |
10%
povidone iodine or 70% alcohol |
10%
povidone iodine |
|
|
%
incidence |
1.98 |
|
|
|
(numbers) |
9/54 |
|
|
|
per
1000 pat days |
|
4 |
|
|
Chlor hexidine |
Formulation |
|
|
|
|
%
incidence |
0.46 |
|
|
|
(numbers) |
1/214 |
|
|
|
per
1000 pat days |
|
|
|
|
Sequential |
%
incidence |
|
|
|
|
|
(numbers) |
|
|
|
|
|
per
1000 pat days |
|
3 |
|
|
Chlor hexidine v. Iodine |
RR(95% CI)
Relative Risk |
N/S
RR 0.7
95%CI 0.1-2.2 p=0.4 |
N/S |
|
|
CVCs Only |
|
First Author of Trial (refernce): |
Maki (1) |
Mimoz (2) |
Humar (3) |
|
Catheter Related Bacteraemia |
|
|
|
|
Control
Group
|
Control Agent(s) |
10%
povidone iodine or 70% alcohol |
10%
povidone iodine |
10%
povidone iodine |
|
%
incidence |
6.4 |
|
3.4 |
|
(numbers) |
7/109 |
|
4/117 |
|
per
1000 pat days |
|
|
4.1 |
|
Chlor hexidine |
Formulation |
2%
aqueous |
0.25%
4%
alcohol |
0.5% tincture |
|
%
incidence |
1.4 |
|
3.2 |
|
(numbers) |
1/67 |
|
4/125 |
|
per
1000 pat days |
|
|
4.6 |
|
Sequential |
%
incidence |
|
|
|
|
|
(numbers) |
|
|
|
|
|
per
1000 pat days |
not
tested |
not
tested |
not
tested |
|
Chlor hexidine v. Iodine |
RR(95% CI)
Relative Risk |
|
|
N/S | |